Can nimodipine help reduce drinking?
Treatments studied
Part of Mental health clinical trials.
This study tests whether a blood pressure medication called nimodipine can help reduce drinking in people with alcohol use disorder. If you are a heavy drinker and not seeking treatment right now, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 50 years old.
- You have moderate or severe alcohol use disorder, as defined by the DSM-5.
- You drink between 30–70 standard drinks per week (men) or 20–65 per week (women).
- You are not currently in or seeking alcohol treatment, and have not been in the past 6 months.
- You do not have other substance use disorders (except tobacco or mild cannabis use) and are not taking certain blood pressure or seizure medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a blood pressure medication called nimodipine can help reduce alcohol drinking in people with moderate to severe alcohol use disorder. You'll take the medication or a placebo and participate in drinking sessions to see how it affects your alcohol intake.
This study tests whether a new medication called NTX-2001 can help people with alcohol use disorder drink less. Researchers will measure how the drug affects alcohol consumption and safety in adults aged 21–60.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
This study tests whether starting certain medications in the emergency room can help people with moderate to severe alcohol use disorder reduce heavy drinking and withdrawal problems after they leave the ER. It compares outcomes for participants who receive the study medications soon after an ER visit.
This early-phase study looks at how the brain’s opioid receptor balance may be different in people with alcohol use disorder (AUD), using brain scans and blood testing. It may help researchers understand why some people respond differently to alcohol and related treatments.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.